- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 11 residues within 4Å:- Chain A: S.588, S.591, A.592, N.595, Q.697
- Chain B: L.67, H.69, E.233, Y.234, R.311
- Ligands: EDO.31
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.233, B:R.311, B:R.311, B:L.67, B:H.69
- Water bridges: B:H.69, B:H.69
NAG-NAG-BMA-MAN-MAN.20: 11 residues within 4Å:- Chain A: L.67, H.69, E.233, Y.234, R.311
- Chain B: S.588, S.591, A.592, N.595, Q.697
- Ligands: EDO.13
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.233, A:R.311, A:R.311, A:L.67, A:H.69
- Water bridges: A:H.69, A:H.69
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.4: 5 residues within 4Å:- Chain A: Y.84, E.94, I.95, N.97, L.100
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Y.84, A:L.100
NAG-NAG-BMA-FUC.22: 5 residues within 4Å:- Chain B: Y.84, E.94, I.95, N.97, L.100
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:Y.84, B:L.100
- 4 x ZN: ZINC ION(Non-covalent)
ZN.6: 6 residues within 4Å:- Chain A: D.344, E.382, Y.509, H.510
- Ligands: ZN.7, TKZ.18
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.344, A:E.382, A:E.382, A:H.510, H2O.12
ZN.7: 6 residues within 4Å:- Chain A: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.6
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.334, A:D.344, A:D.410, A:D.410, H2O.12
ZN.24: 6 residues within 4Å:- Chain B: D.344, E.382, Y.509, H.510
- Ligands: ZN.25, TKZ.36
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.344, B:E.382, B:E.382, B:H.510, H2O.30
ZN.25: 6 residues within 4Å:- Chain B: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.24
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.334, B:D.344, B:D.410, B:D.410, H2O.30
- 2 x CA: CALCIUM ION(Non-covalent)
CA.8: 4 residues within 4Å:- Chain A: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:T.226, A:Y.229, A:E.390, A:E.390, A:E.393
CA.26: 4 residues within 4Å:- Chain B: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:T.226, B:Y.229, B:E.390, B:E.390, B:E.393
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 2 residues within 4Å:- Chain A: N.152, S.154
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.152, A:S.154
NAG.11: 4 residues within 4Å:- Chain A: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.203, A:Y.523
- Hydrogen bonds: A:W.203, A:F.522
- Water bridges: A:N.416
NAG.28: 2 residues within 4Å:- Chain B: N.152, S.154
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.152, B:S.154
NAG.29: 4 residues within 4Å:- Chain B: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:W.203, B:Y.523
- Hydrogen bonds: B:W.203, B:F.522
- Water bridges: B:N.416
- 6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.12: 4 residues within 4Å:- Chain A: N.14, M.15, F.542, E.543
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:M.15, A:E.543
- Water bridges: A:N.14, A:K.16
EDO.13: 4 residues within 4Å:- Chain A: Q.54, E.66, L.67
- Ligands: NAG-NAG-BMA-MAN-MAN.20
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.54, A:L.67, A:L.67
EDO.15: 6 residues within 4Å:- Chain A: P.461, E.462, P.467, R.468, I.469
- Ligands: TKZ.18
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.462, A:R.468, A:I.469
EDO.30: 4 residues within 4Å:- Chain B: N.14, M.15, F.542, E.543
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:M.15, B:E.543
- Water bridges: B:N.14, B:K.16
EDO.31: 4 residues within 4Å:- Chain B: Q.54, E.66, L.67
- Ligands: NAG-NAG-BMA-MAN-MAN.2
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.54, B:L.67, B:L.67
EDO.33: 6 residues within 4Å:- Chain B: P.461, E.462, P.467, R.468, I.469
- Ligands: TKZ.36
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.462, B:R.468, B:I.469
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.16: 4 residues within 4Å:- Chain A: Y.108, Y.199, T.515, E.517
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Y.199, A:T.515, A:E.517
NA.17: 3 residues within 4Å:- Chain A: E.443, K.457, Y.529
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.443, A:E.443
NA.34: 4 residues within 4Å:- Chain B: Y.108, Y.199, T.515, E.517
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Y.199, B:Y.199, B:T.515
NA.35: 3 residues within 4Å:- Chain B: E.443, K.457, Y.529
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.443, B:E.443
- 2 x TKZ: (((S)-1-carboxy-5-((E)-2-cyano-3-(5-(1-(3-methoxy-3-oxopropyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophen-2-yl)acrylamido)pentyl)carbamoyl)-L-glutamic acid(Non-covalent)
TKZ.18: 27 residues within 4Å:- Chain A: G.163, K.164, V.165, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, S.470, K.471, G.475, N.476, R.491, R.493, F.503, G.505, Y.509, H.510, N.655, K.656, Y.657, A.658
- Ligands: ZN.6, EDO.15
28 PLIP interactions:28 interactions with chain A- Hydrophobic interactions: A:L.385, A:F.503, A:F.503, A:Y.509, A:Y.657, A:Y.657
- Hydrogen bonds: A:N.214, A:G.475, A:G.475, A:N.476, A:G.505, A:Y.657
- Water bridges: A:R.167, A:K.170, A:N.214, A:D.344, A:E.414, A:R.468, A:R.491, A:S.504, A:K.656
- Salt bridges: A:R.167, A:K.471, A:R.491, A:R.493, A:H.510, A:K.656
- pi-Stacking: A:F.503
TKZ.36: 27 residues within 4Å:- Chain B: G.163, K.164, V.165, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, S.470, K.471, G.475, N.476, R.491, R.493, F.503, G.505, Y.509, H.510, N.655, K.656, Y.657, A.658
- Ligands: ZN.24, EDO.33
28 PLIP interactions:28 interactions with chain B- Hydrophobic interactions: B:L.385, B:F.503, B:F.503, B:Y.509, B:Y.657, B:Y.657
- Hydrogen bonds: B:N.214, B:G.475, B:G.475, B:N.476, B:G.505, B:Y.657
- Water bridges: B:R.167, B:K.170, B:N.214, B:D.344, B:E.414, B:R.468, B:R.491, B:S.504, B:K.656
- Salt bridges: B:R.167, B:K.471, B:R.491, B:R.493, B:H.510, B:K.656
- pi-Stacking: B:F.503
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, J. et al., A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nat Commun (2021)
- Release Date
- 2021-08-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.73 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 2 x TKZ: (((S)-1-carboxy-5-((E)-2-cyano-3-(5-(1-(3-methoxy-3-oxopropyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophen-2-yl)acrylamido)pentyl)carbamoyl)-L-glutamic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, J. et al., A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nat Commun (2021)
- Release Date
- 2021-08-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A